TELUS Health empowers Canadians to better manage their medications

MONTREAL, QUEBEC–(Marketwired – July 24, 2017) – TELUS Health today announced that Pharma Space, its technology service that helps patients manage their prescriptions through features like scheduling online reminders and automatic refills is now being accessed by more than 300,000 customers. For these customers, Pharma Space helps to ensure adherence to medication treatment plans and reduces unnecessary trips to the pharmacy.

A 2014 report by the Canadian Institute for Health Information found that two-thirds of Canadians over the age of 65 have five or more different prescriptions, and one-quarter take 10 or more prescription drugs. Pharma Space provides patients with the flexibility to better manage these prescriptions as well as their online drug profile anytime, anywhere from a mobile phone, tablet or computer. The online system also allows patients access to information they need about the medications they’re taking, including potential side effects.

“Patients expect to have the technology they need at their fingertips to be proactive with the management of their own health. Pharma Space enables patients to play a larger role in managing their own medications,” said Paul Lepage, President, TELUS Health. “Consumer-focused digital health tools can have a significant impact on the health and well-being of all Canadians. When doctors and pharmacists embrace digital technology it can ensure patients stick with treatment plans and lead to better health outcomes.”

Through the Pharma Space service, prescription refill reminders help patients remember to renew prescriptions, which results in better adherence to drug treatment plans. Easier medication management by way of automated refill requests for the duration of the prescription are possible with simple online requests directly from Pharma Space to a pharmacist’s dispensing system. Patients can also get organized for doctor’s appointments through easily accessible medication lists and ease the pain of tax returns by printing prescription summaries at tax time.

Caregivers can use Pharma Space to access the profiles of family members under their care and provide better support particularly for those who are either too young or ill to manage it themselves. For pharmacists, integrating Pharma Space into their pharmacy management software increases efficiencies and allows for better care coordination and information flow among healthcare providers.

Pharma Space is currently available through participating pharmacies. Patients are encouraged to speak with their pharmacist to discuss TELUS Pharma Space availability or learn more about Pharma Space here.

QUOTES:

“Pharma Space simplifies medication management for the patient as well as us, the pharmacists” said Grégoire Arakelian, pharmacist and Costco-affiliated pharmacy owner, Montreal, Quebec. “The automatic refills and scheduled reminders decreases pressure on pharmacists by enabling us to plan our workday, thus freeing up additional time to serve patients visiting the pharmacy.”

“This is a great tool to manage a child’s prescription or to make sure aging parents are on top of their medications. It’s really about helping to increase drug compliance by providing access to complete personal drug profiles and easy online refills,” said Dean Pepper, pharmacy owner, Cobourg, Ontario.

“The phone is ringing less, and patients can use their online profiles to get the information they need about medication side effects and other specifics about the medications they’re on,” said Ron Mack, pharmacist and pharmacy owner, Saskatoon, Saskatchewan. “Pharma Space is a great advantage for our pharmacy, and patients find it intuitive to use.”

About TELUS Health

TELUS Health is a leader in telehomecare, electronic medical and health records, consumer health, benefits management, and pharmacy management. TELUS Health solutions give health authorities, providers, physicians, patients, and consumers the power to turn information into better health outcomes. For more information about TELUS Health, please visit telushealth.com.

Contact Information:
Jill Yetman
TELUS Corporate Communications
(416) 992-2639
Jill.Yetman@telus.com

Raeanna Group Committed to Deploy over 1000 Sites in Nigeria using NuRAN’s GSM Solution

QUEBEC, QUEBEC–(Marketwired – July 24, 2017) – NuRAN Wireless Inc. (“NuRAN Wireless” or the “Company”) (CSE:NUR)(CSE:NUR.CN)(CNSX:NUR)(OTC:NRRWF) is pleased to announce that its GSM LiteRAN 2G solution was selected by Raeanna Group, a wholesale operator. Raeanna Group is now committed to the deployment of over 1000 sites in Nigeria over the next five years. This commitment is further to the May 25 press release whereby NuRAN had announced receiving an order for hundreds of sites from an undisclosed Tier One Operator in Africa worth over $4 Million.

The initial deployment of NuRAN’s complete Radio Access Network was performed in February 2017 in five sites located in semi-urban and rural areas of Nigeria in the states of Delta, Bayelsa and Akwa Ibom.

“As an innovative technology company, Raeanna has in its vision to transform hamlets and villages within Nigeria and other African countries with a view to improving the standard of living within our rural communities. This is achieved through the deployment of low powered base transceiver station (BTS) sites in previously un-served and under-served communities.

The deployment of these BTS sites which provides data and voice services to the communities has provided Raeanna a unique platform for the implementation of e-centres in these communities. These e-centres provide e-banking, e-learning and e-clinic services among others.

Raeanna in conjunction with its Canadian strategic partners NuRAN Wireless and Clear Blue Technologies have committed to deploying over 1000 of BTS sites and e-centre solutions throughout Nigeria over the next five years.” explained Tunji Alabi, Executive Director at Raeanna Group.

2G remains an important technology in Sub-Saharan Africa. The 2017 GSMA Mobile Economy report states that Sub-Saharan Africa is still dominated by 2G networks with approximately 61% of its subscribers. With two thirds of the population in Sub-Saharan Africa living in rural and remote communities and with total unique subscriber penetration at 44%, there’s still a lot of work to do in connecting these communities.

“This deployment continues to demonstrate the strength of the NuRAN Wireless portfolio of products and its relevance and need for markets such as Nigeria. The importance of connecting these communities remains at the forefront of what we strive to achieve. The potential for the rest of the African continent remains enormous” states Bradley Shaw, Regional Manager Middle East and Africa for NuRAN Wireless.

The impact of connectivity and of the services it allows such as e-banking on the social and economic development of these communities is highly important and critical. Based on a Deloitte study of 74 countries realized for GSMA, a 10% increase in mobile penetration increases Total Factor Productivity in the long run by 4.2%.

“Light has shined and darkness has been given way in our dear community in Idheze, Isoko local government area of Delta State, Nigeria, by the worthy provision of network infrastructure triggered by Raeanna Nigeria limited and its partners. On behalf of Idheze community, I wish to say many thanks to the precursors of the network infrastructure- the entire management of Raeanna Group for a task well accomplished. Bravo and Gracias!!” claimed Chris Olakpe, Aig (Chief) of the Idheze community.

About NuRAN Wireless

NuRAN Wireless is a leading supplier of mobile and broadband wireless solutions. Its innovative GSM, LTE, and White Space radio access network (RAN) and backhaul products dramatically drop the total cost of ownership, thereby creating new opportunities for mobile network operators and internet service providers.

The Corporation provides a variety of specialist systems for indoor coverage, rural and urban connectivity in emerging markets, connectivity to offshore platforms and ships, and for emergency and crisis communications.

No regulatory authority has approved or disapproved the information contained in this news release.

Forward Looking Statements

This press release contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of NuRAN Wireless to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Examples of such statements include: the Company’s quest to connect the next billion; that this strategic acquisition allows Nuran to offer a complete mobile and broadband solution and the ability to secure the Nuran solution as the leader in rural and remote mobile connectivity, that the acquisition reinforces NuRAN’s strategic positioning towards new and small operators by offering an end-to-end mobile small-cell network solution with the lowest Total-Cost-of-Ownership (TCO) on the market and that the acquisition will allow NuRAN the opportunity to bring cellular coverage to emerging market where the return on investment (ROI) was previously simply too low. Actual results and developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this press release. Such forward-looking statements are based on a number of assumptions which may prove to be incorrect, including, but not limited to: the ability of NurRAN Wireless to obtain necessary financing; general economic conditions in Canada and globally; competition for, among other things, capital and skilled personnel; our ability to hire and retain qualified employees and key management personnel; possibility that government policies or laws may change; possible disruptive effects of organizational or personnel changes; technological change, new products and standards; risks related to acquisitions and international expansion; reliance on large customers; reliance on a limited number of suppliers; risks related to the Company’s competition; failure to integrate the technology and assets acquired from the Vendors and the Company’s failure to adequately protect its intellectual property; interruption or failure of information technology systems and other risk factors described in the Company’s reports filed on SEDAR), including its financial statements for the year ended October 31, 2015, and those referred to under the heading “Risk Factors”. These forward-looking statements should not be relied upon as representing NuRAN Wireless’ views as of any date subsequent to the date of this press release.

Contact Information:
For further Information about
NuRAN Wireless or Nutaq Innovations
www.nuranwireless.com
www.nutaq.com

Martin Bedard and Patrice Rainville
Co-Presidents and Co-CEOs
(418) 914-7484
Toll Free: 1-855-914-7484
(418) 914-9477 (FAX)
info@nuranwireless.com
info@nutaq.com

Spectra7 Completes Private Placement

SAN JOSE, CA
–(Marketwired – July 24, 2017) –
(TSX: SEV) Spectra7 Microsystems Inc., (“Spectra7” or the “Company”), a leading provider of high-performance analog semiconductor products for broadband connectivity markets, today announced the closing of the final tranche of its previously announced private placement of units (“Units”) consisting of one common share of the Company and one-half of one common share purchase warrant. The aggregate gross proceeds of the private placement, inclusive of the proceeds from the first tranche which closed on June 27, 2017 and $337,000 of subscriptions from the CEO and certain directors of the Company, is $1.4 million. This closing follows the previously disclosed $4.6 million bought deal public offering of Units closed by the Company on June 27, 2017 for aggregate gross proceeds of $6.0 million. The net proceeds from the financings will be used for research and development and general corporate purposes.

“Along with our continuing efforts to reduce operating expenses and grow revenues, these financings strengthen our balance sheet and allow us to develop our next generation of products,” said Spectra7 CEO Raouf Halim. “In the meantime, the virtual, augmented, and mixed reality markets continue to adopt our technology, and the Company is experiencing strong market traction with data center operators.”

The Company continues to advance the sale of its non-core Television tuner/demodulator and RF patents. Currently there are multiple parties doing due diligence. Although we cannot guarantee that this sale will proceed or provide a timeline, our discussions with these potential purchasers suggests that the previously disclosed estimate of $4 million plus potential future royalties remains a good target value for these assets.

ABOUT SPECTRA7 MICROSYSTEMS INC.

Spectra7 Microsystems Inc. is a high-performance analog semiconductor company delivering unprecedented bandwidth, speed and resolution to enable disruptive industrial design for leading electronics manufacturers in broadband connectivity markets. Spectra7 is based in San Jose, California with design centers in Markham, Ontario, Cork, Ireland, and Little Rock, Arkansas. For more information, please visit www.spectra7.com.

CAUTIONARY NOTES

Certain statements contained in this press release constitute “forward-looking statements”. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s future financial position and results of operations, strategy, proposed acquisitions, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to the risk factors discussed in the Company’s annual MD&A for the year ended December 31, 2016. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law.

For more information, please contact:

Spectra7 Microsystems Inc.
Sean Peasgood
Investor Relations
416-565-2805
ir@spectra7.com

Spectra7 Microsystems Inc.
David Mier
Chief Financial Officer
669-284-3170
pr@spectra7.com